603538.SS SHH
Ningbo Menovo Pharmaceutical Co., Ltd.
1W: -0.8%
1M: +8.1%
3M: +2.1%
YTD: +33.6%
1Y: +9.7%
3Y: +55.8%
5Y: -7.1%
¥28.59 ($4.26)
+2.60 (+10.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥9.7B ($1.4B)
52W Range13.55-50.28
Volume47,551,922
Avg Volume55,084,321
Beta-0.05
Dividend¥0.15
Analyst Ratings
No analyst coverage
Company Info
CEOCheng Zhi Yao
Employees2,370
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2017-04-10
Websitemenovopharm.com
Building1,Ningbo R&D Park
Ningbo, ZH 315048
CN
Ningbo, ZH 315048
CN
86 57 4879 18601
About Ningbo Menovo Pharmaceutical Co., Ltd.
Ningbo Menovo Pharmaceutical Co., Ltd. operates across the full spectrum of pharmaceutical activities, encompassing the research, development, production, and distribution of medicinal products. Their extensive product line features Active Pharmaceutical Ingredients (APIs), intermediate chemicals, and finished drug formulations. These offerings are designed to address a wide range of therapeutic areas, including cardiovascular, central nervous system, respiratory, oncological, anti-infective, digestive, and geriatric disorders, as well as antiviral treatments. The company commenced operations in 2004 and maintains its principal place of business in Ningbo, China.
Latest News
No recent news
Recent Insider Trades
No insider trades found